Rep. Gilbert Ray Cisneros, Jr. Buys Stryker Corporation (NYSE:SYK) Shares

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Stryker Corporation (NYSE:SYK). In a filing disclosed on December 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in Stryker stock on November 18th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 11/26/2025.
• Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 11/26/2025.
• Purchased $1,001 – $15,000 in shares of First Watch Restaurant Group (NASDAQ:FWRG) on 11/26/2025.
• Purchased $1,001 – $15,000 in shares of TKO Group (NYSE:TKO) on 11/26/2025.
• Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 11/24/2025.
• Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 11/24/2025.
• Purchased $1,001 – $15,000 in shares of Logan Energy (CVE:LGN) on 11/24/2025.
• Sold $1,001 – $15,000 in shares of Primoris Services (NASDAQ:PRIM) on 11/24/2025.
• Purchased $15,001 – $50,000 in shares of LandBridge (NYSE:LB) on 11/21/2025.
• Purchased $50,001 – $100,000 in shares of LandBridge (NYSE:LB) on 11/20/2025.

Stryker Price Performance

Stryker stock traded up $2.10 on Friday, reaching $355.21. The company’s stock had a trading volume of 2,755,021 shares, compared to its average volume of 1,470,531. The business’s fifty day moving average price is $365.45 and its 200 day moving average price is $377.69. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $406.19. The company has a market cap of $135.84 billion, a price-to-earnings ratio of 46.68, a PEG ratio of 2.50 and a beta of 0.89.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The company had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Equities analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. This is a boost from Stryker’s previous quarterly dividend of $0.84. The ex-dividend date is Wednesday, December 31st. Stryker’s dividend payout ratio (DPR) is presently 44.15%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Sanford C. Bernstein reissued an “outperform” rating on shares of Stryker in a research note on Monday, November 3rd. Redburn Partners set a $420.00 price target on Stryker in a report on Thursday, September 18th. Rothschild Redb upgraded Stryker to a “hold” rating in a research note on Thursday, September 18th. Truist Financial cut their price target on shares of Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a report on Thursday. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $448.00 target price on shares of Stryker in a research report on Friday, November 14th. Thirteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $431.84.

Insider Transactions at Stryker

In other Stryker news, CFO Preston Wendell Wells sold 165 shares of the stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $365.88, for a total transaction of $60,370.20. Following the sale, the chief financial officer directly owned 6,694 shares in the company, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the company’s stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the transaction, the director owned 2,702,108 shares in the company, valued at $954,600,714.24. This represents a 9.27% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 522,118 shares of company stock valued at $185,381,932. Corporate insiders own 5.90% of the company’s stock.

Institutional Investors Weigh In On Stryker

Several large investors have recently made changes to their positions in the business. Mirabella Financial Services LLP grew its stake in Stryker by 124.4% during the third quarter. Mirabella Financial Services LLP now owns 10,248 shares of the medical technology company’s stock valued at $3,781,000 after acquiring an additional 5,681 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in Stryker in the 3rd quarter worth $55,000. Hudson Bay Capital Management LP grew its position in Stryker by 130.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 568 shares of the medical technology company’s stock worth $210,000 after acquiring an additional 2,430 shares during the last quarter. Severin Investments LLC raised its holdings in Stryker by 24.1% during the 3rd quarter. Severin Investments LLC now owns 1,499 shares of the medical technology company’s stock valued at $554,000 after buying an additional 291 shares during the last quarter. Finally, Swiss Life Asset Management Ltd lifted its holdings in Stryker by 7.0% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 37,984 shares of the medical technology company’s stock worth $14,042,000 after buying an additional 2,486 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.